Corticosteroid rhythms in hypoparathyroid patients.

IF 5.3 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM European Journal of Endocrinology Pub Date : 2024-08-30 DOI:10.1093/ejendo/lvae102
Marianne C Astor, Kristian Løvås, Paal Methlie, Katerina Simunkova, Jörg Assmus, Eystein S Husebye
{"title":"Corticosteroid rhythms in hypoparathyroid patients.","authors":"Marianne C Astor, Kristian Løvås, Paal Methlie, Katerina Simunkova, Jörg Assmus, Eystein S Husebye","doi":"10.1093/ejendo/lvae102","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Previous studies indicate a possible bidirectional stimulatory relationship between parathyroid hormone (PTH) and adrenocortical hormones, but the pattern of adrenocortical secretion in hypoparathyroidism is unknown. We aimed to characterize the adrenocortical secretion in patients with postsurgical hypoparathyroidism, and whether continuous subcutaneous PTH (1-34) infusion alters secretion patterns.</p><p><strong>Design: </strong>Crossover interventional study.</p><p><strong>Methods: </strong>We recruited 10 patients with postsurgical hypoparathyroidism with very low PTH levels on stable treatment with active vitamin D and calcium. Cortisol, cortisone, and aldosterone levels were measured in microdialysate from subcutaneous tissue over 24 h, before and during continuous subcutaneous PTH (1-34) infusion. Cortisol was also assayed in serum, saliva, and urine, and aldosterone and ACTH in serum and plasma, respectively. Ten patients with primary hyperparathyroidism and 10 healthy volunteers matched for sex and age served as controls.</p><p><strong>Results: </strong>Hypoparathyroid patients displayed both ultradian and circadian rhythmicity for tissue cortisol, cortisone, and aldosterone. Tissue aldosterone and cortisone levels were significantly lower in hypoparathyroid patients than in healthy controls, with no difference in tissue cortisol, but a higher cortisol to cortisone ratio. Treatment with PTH (1-34) increased tissue levels of aldosterone, cortisol, and cortisone and reduced the ratio of cortisol to cortisone.</p><p><strong>Conclusion: </strong>Adrenocortical hormone levels are reduced in postsurgical hypoparathyroidism, and partly restored by short-term continuous subcutaneous PTH (1-34) therapy.</p><p><strong>Clinical trial registration number: </strong>NCT02986607.</p>","PeriodicalId":11884,"journal":{"name":"European Journal of Endocrinology","volume":" ","pages":"271-278"},"PeriodicalIF":5.3000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejendo/lvae102","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Previous studies indicate a possible bidirectional stimulatory relationship between parathyroid hormone (PTH) and adrenocortical hormones, but the pattern of adrenocortical secretion in hypoparathyroidism is unknown. We aimed to characterize the adrenocortical secretion in patients with postsurgical hypoparathyroidism, and whether continuous subcutaneous PTH (1-34) infusion alters secretion patterns.

Design: Crossover interventional study.

Methods: We recruited 10 patients with postsurgical hypoparathyroidism with very low PTH levels on stable treatment with active vitamin D and calcium. Cortisol, cortisone, and aldosterone levels were measured in microdialysate from subcutaneous tissue over 24 h, before and during continuous subcutaneous PTH (1-34) infusion. Cortisol was also assayed in serum, saliva, and urine, and aldosterone and ACTH in serum and plasma, respectively. Ten patients with primary hyperparathyroidism and 10 healthy volunteers matched for sex and age served as controls.

Results: Hypoparathyroid patients displayed both ultradian and circadian rhythmicity for tissue cortisol, cortisone, and aldosterone. Tissue aldosterone and cortisone levels were significantly lower in hypoparathyroid patients than in healthy controls, with no difference in tissue cortisol, but a higher cortisol to cortisone ratio. Treatment with PTH (1-34) increased tissue levels of aldosterone, cortisol, and cortisone and reduced the ratio of cortisol to cortisone.

Conclusion: Adrenocortical hormone levels are reduced in postsurgical hypoparathyroidism, and partly restored by short-term continuous subcutaneous PTH (1-34) therapy.

Clinical trial registration number: NCT02986607.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
甲状旁腺功能减退症患者的皮质类固醇节律。
研究目的以往的研究表明,甲状旁腺激素(PTH)和肾上腺皮质激素之间可能存在双向刺激关系,但甲状旁腺功能减退症患者肾上腺皮质的分泌模式尚不清楚。我们旨在了解手术后甲状旁腺功能减退症患者肾上腺皮质分泌的特点,以及持续皮下注射PTH(1-34)是否会改变分泌模式:设计:交叉干预研究:我们招募了10名PTH水平极低的术后甲状旁腺功能减退症患者,他们正在接受活性维生素D和钙的稳定治疗。皮质醇、可的松和醛固酮水平是在皮下注射 PTH (1-34) 前和持续皮下注射 PTH (1-34) 期间 24 小时内通过皮下组织微量裂解液进行测定的。此外,还检测了血清、唾液和尿液中的皮质醇,以及血清和血浆中的醛固酮和促肾上腺皮质激素。10 名原发性甲状旁腺功能亢进症患者和 10 名性别和年龄匹配的健康志愿者作为对照组:结果:甲状旁腺功能减退症患者的组织皮质醇、可的松和醛固酮均显示出超昼夜节律性和昼夜节律性。甲状旁腺功能减退症患者的组织醛固酮和可的松水平明显低于健康对照组,组织皮质醇没有差异,但皮质醇与可的松的比率较高。用PTH(1-34)治疗可增加组织中的醛固酮、皮质醇和可的松水平,并降低皮质醇与可的松的比率:结论:手术后甲状旁腺功能减退症患者的肾上腺皮质激素水平会降低,而短期持续皮下注射PTH(1-34)治疗可部分恢复这一水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Journal of Endocrinology
European Journal of Endocrinology 医学-内分泌学与代谢
CiteScore
9.80
自引率
3.40%
发文量
354
审稿时长
1 months
期刊介绍: European Journal of Endocrinology is the official journal of the European Society of Endocrinology. Its predecessor journal is Acta Endocrinologica. The journal publishes high-quality original clinical and translational research papers and reviews in paediatric and adult endocrinology, as well as clinical practice guidelines, position statements and debates. Case reports will only be considered if they represent exceptional insights or advances in clinical endocrinology. Topics covered include, but are not limited to, Adrenal and Steroid, Bone and Mineral Metabolism, Hormones and Cancer, Pituitary and Hypothalamus, Thyroid and Reproduction. In the field of Diabetes, Obesity and Metabolism we welcome manuscripts addressing endocrine mechanisms of disease and its complications, management of obesity/diabetes in the context of other endocrine conditions, or aspects of complex disease management. Reports may encompass natural history studies, mechanistic studies, or clinical trials. Equal consideration is given to all manuscripts in English from any country.
期刊最新文献
Response to "Advancing understanding of metabolic consequences of Cholecystectomy: review reflection". Advancing understanding of metabolic consequences of a Cholecystectomy: review reflection. Prevalence and determinants of dyslipidemia in 2,338 Dutch childhood cancer survivors: a DCCS-LATER 2 Study. Cardiovascular status in endogenous cortisol excess: the prospective CV-CORT-EX study. Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism. A cohort study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1